B-ALL patients exhibit an increase in CD4+ T and CD8+ T cells along with a peculiar profile of soluble mediators marked by an increase in CXCL9, CXCL10, IL-6 and IL-10. The gene discussed is CD4; the disease is precursor B-cell acute lymphoblastic leukemia.